Key facts
- It has raised $3.4M.
- Notable investors include Newfund Management, Galion.exe, Brain&Mind, Cenitz, PC'up Incubator — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Oria Bioscience
- ·The full record, as it builds
Funding rounds
No funding rounds for Oria Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oria Bioscience
Developer of organelle-based research tools designed for pharmaceutical and drug discovery applications. The company's tool facilitates throughput screening with purified organelles, incorporating stable and biological components, enabling pharmaceutical scientists to refine hit-to-lead optimization and conduct in-depth analyses of disease mechanisms.
- Sector
- Healthcare
- HQ
- Paris, France
- Website
- oriabs.com/
- Ownership
- Privately Held (backing)
Oria Bioscience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oria Bioscience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oria Bioscience in its N-PORT filings yet. We sweep new filings monthly.